Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
Sign up today and learn more about Aravax Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Aravax Stock
Chief Operating Officer and Co-Founder
Co-Founder, Chief Scientific Officer